REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,153,051 | +1773.0% | 89,771 | +1570.2% | 0.00% | – |
| Q1 2023 | $488,695 | +42.5% | 5,375 | -40.4% | 0.00% | – |
| Q4 2022 | $343,000 | +67.3% | 9,016 | +10.1% | 0.00% | – |
| Q3 2022 | $205,000 | -32.6% | 8,190 | +171.6% | 0.00% | – |
| Q3 2021 | $304,000 | -97.9% | 3,015 | -97.1% | 0.00% | -100.0% |
| Q2 2021 | $14,609,000 | +42.6% | 103,226 | +0.5% | 0.01% | +66.7% |
| Q1 2021 | $10,243,000 | +4.3% | 102,734 | +29.3% | 0.00% | 0.0% |
| Q4 2020 | $9,822,000 | +66.7% | 79,453 | +31.4% | 0.00% | +50.0% |
| Q3 2020 | $5,892,000 | -84.3% | 60,475 | -74.9% | 0.00% | -87.5% |
| Q2 2020 | $37,580,000 | +21.1% | 240,868 | +12.0% | 0.02% | 0.0% |
| Q1 2020 | $31,030,000 | +39.7% | 214,971 | +97.8% | 0.02% | +77.8% |
| Q4 2019 | $22,214,000 | +224.0% | 108,666 | +27.2% | 0.01% | +200.0% |
| Q3 2019 | $6,857,000 | -44.5% | 85,411 | -34.7% | 0.00% | -50.0% |
| Q2 2019 | $12,349,000 | +20.2% | 130,886 | +8.9% | 0.01% | +20.0% |
| Q1 2019 | $10,271,000 | +1.1% | 120,173 | -33.6% | 0.01% | 0.0% |
| Q4 2018 | $10,159,000 | -46.8% | 181,077 | -22.5% | 0.01% | -28.6% |
| Q3 2018 | $19,102,000 | +34.3% | 233,628 | -42.6% | 0.01% | +16.7% |
| Q2 2018 | $14,223,000 | +2118.9% | 406,723 | +1200.4% | 0.01% | – |
| Q1 2018 | $641,000 | -28.4% | 31,277 | -1.0% | 0.00% | – |
| Q4 2017 | $895,000 | -10.2% | 31,599 | -1.4% | 0.00% | – |
| Q3 2017 | $997,000 | – | 32,043 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
| IFP Advisors, Inc | 300 | $51,708 | 0.00% |